Point of Care Testing Market Size Expected to Garner USD 71.7 Billion by 2030 growing at 8.8% CAGR - Exclusive Report by Acumen Research and Consulting

Author: Acumen Research and Consulting

The Global Point of Care Testing Market Size is predicted to grow at a CAGR of 8.8% between 2022 and 2030, from USD 33.7 Billion in 2021 to USD 71.7 Billion by 2030, as per the Acumen Research and Consulting

The Point of Care Testing (POCT) market is evolving at a rapid pace with advancements in technology and changing healthcare requirements. POCT provides quick and accurate diagnostic results at the patient's bedside, reducing the need for complex and time-consuming laboratory tests. The increasing demand for faster and more convenient testing, coupled with the rise in the aging population and increasing incidence of chronic diseases is driving the POCT market growth.

In recent years, POCT has witnessed a significant shift from traditional testing methods to mobile and wireless devices, which allow for real-time testing and immediate results. The use of mobile and wearable devices for POCT is growing as they offer enhanced patient convenience, improved accuracy and reliability of test results, and cost savings. The growth in telemedicine and remote patient monitoring is also contributing to the POCT market value, as it enables healthcare providers to monitor patients' health conditions remotely, reducing the need for frequent hospital visits.

Global point of care testing market revenue collected USD 33.7 Billion in 2021, with a 8.8% CAGR between 2022 and 2030

Point of Care Testing Market Statistics

  • Global point of care testing market revenue collected USD 33.7 Billion in 2021, with a 8.8% CAGR between 2022 and 2030
  • North America point of care testing market value gathered more than USD 13.8 Billion in 2021
  • By product, the infectious diseases capture over 20% of total market share in 2021
  • Increasing demand for portable POCT devices, fuels the point of care testing market size
  • Roche is a leading player in the POCT market and offers a wide range of POCT devices for various applications, including glucose monitoring, infectious disease testing, and cardiac markers.

Request for a sample of this premium research report@ https://www.acumenresearchandconsulting.com/request-sample/1136

Point of Care Testing Market Trends                   

Point-of-Care Testing (POCT) is an innovative technology that enables medical professionals to perform diagnostic tests at or near the site of patient care. This technology has revolutionized the healthcare industry by providing rapid, convenient, and cost-effective diagnostic solutions. POCT has emerged as a significant tool for diagnosing various medical conditions and has become an integral part of patient care.

The evolution of POCT has been driven by several factors, including the increasing demand for fast and accurate diagnostic results, the need for decentralized healthcare services, and the advancement of technology. With the advent of new technologies such as microfluidics, biosensors, and nanotechnology, POCT has become more accessible, efficient, and cost-effective.

The POCT market is growing rapidly and is expected to continue its upward trajectory in the coming years. The market is driven by the increasing prevalence of chronic diseases, the growing demand for home-based and remote patient monitoring, and the need for efficient and cost-effective diagnostic solutions. Additionally, the development of innovative POCT devices, such as wearable devices, has further contributed to the point of care testing market growth.

Point of Care Testing Market Segmentation                                

Acumen Research and Consulting has segmented the global point of care testing market by technology, application, product, end-user, prescription, and region.

  • By technology, the market is categorized into biosensors, lateral flow assays, immunoassays, flow-through, microfluidics, dipsticks, molecular diagnostics, agglutination assays, and solid phase.
  • By application, the market is divided into the pregnancy testing, blood glucose testing, cancer biomarker testing, cardio metabolic testing, infectious disease testing, drug-of-abuse (DoA) testing, nephrology testing, and other.
  • By product, the market is bifurcated into the cardiometabolic testing, glucose monitoring, coagulation testing, infectious disease testing, tumor/cancer marker testing, pregnancy and fertility testing, urinalysis testing, fecal occult testing, drug-of-abuse (DoA) testing, hematology testing, cholesterol testing, and other.
  • By end-user, the market is split into laboratories, hospitals & clinics, assisted living healthcare facilities, home-care settings, and others.
  • By prescription, the market is classified into prescription-based testing, and OTC testing.
  • By region, the market is segmented into Latin America, Asia-Pacific, North America, Europe, and the MEA.

Point of Care Testing Market Regional Overview                                   

Geographically, North America holds the largest share of the Point of Care Testing (POCT) market. This growth is due to several factors, including a well-established healthcare infrastructure and high healthcare expenditure. In North America, governments have implemented favorable initiatives and policies to support the use of POCT, driving growth in the market. Additionally, the presence of major POCT device manufacturers and suppliers in North America has also contributed to the region's dominant market share. Growing POCT device adoption is another factor in North America's significant point of care testing market share. These devices provide fast and accurate results, leading to improved patient outcomes and reduced healthcare costs. This has resulted in a growing demand for POCT devices in North America, further boosting the market.

Point of Care Testing Market Players                   

Some of the major points of care testing market companies are Zoetis, Inc., Nova Biomedical, Siemens Healthcare AG, Biomerieux SA, Abbott Laboratories, Trividia Health, Inc., Danaher Corp., Becton Dickinson (BD), Instrumentation Laboratory, Qiagen, and F. Hoffmann-La Roche Ltd.        

Click here to buy the Premium Market Research report https://www.acumenresearchandconsulting.com/buy-now/0/1136

Receive our personalized services and customization by clicking here https://www.acumenresearchandconsulting.com/request-customization/1136

Mr. Frank Wilson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533

E-mail: sales@acumenresearchandconsulting.com